ZA200207107B - New combination of a betablocker and a cholesterol-lowering agent. - Google Patents

New combination of a betablocker and a cholesterol-lowering agent.

Info

Publication number
ZA200207107B
ZA200207107B ZA200207107A ZA200207107A ZA200207107B ZA 200207107 B ZA200207107 B ZA 200207107B ZA 200207107 A ZA200207107 A ZA 200207107A ZA 200207107 A ZA200207107 A ZA 200207107A ZA 200207107 B ZA200207107 B ZA 200207107B
Authority
ZA
South Africa
Prior art keywords
betablocker
cholesterol
lowering agent
new combination
new
Prior art date
Application number
ZA200207107A
Inventor
Goeran Bondjers
John Wikstrand
Olov Wiklund
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200207107B publication Critical patent/ZA200207107B/en

Links

ZA200207107A 2000-04-03 2002-09-04 New combination of a betablocker and a cholesterol-lowering agent. ZA200207107B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001188A SE0001188D0 (en) 2000-04-03 2000-04-03 New combination

Publications (1)

Publication Number Publication Date
ZA200207107B true ZA200207107B (en) 2003-12-04

Family

ID=20279127

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200207107A ZA200207107B (en) 2000-04-03 2002-09-04 New combination of a betablocker and a cholesterol-lowering agent.

Country Status (2)

Country Link
SE (1) SE0001188D0 (en)
ZA (1) ZA200207107B (en)

Also Published As

Publication number Publication date
SE0001188D0 (en) 2000-04-03

Similar Documents

Publication Publication Date Title
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
AU9667901A (en) Mycoattractants and mycopesticides
MXPA03004714A (en) Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents.
EP1151667A3 (en) Plant-activating agent
HK1051325A1 (en) New combination of a betablocker and a cholesterol-lowering agent
AU2001242985A1 (en) New combination of a betablocker and a cholesterol-lowering agent
HUP0105019A3 (en) Use of cholesterol-lowering agent
GB2365032B (en) A sectional structure and parts thereof
HUP0000997A3 (en) New medicament combination
GB0007530D0 (en) Trityl-type compounds and their use
GB0021497D0 (en) Compounds and their use
EP1291461A4 (en) Color-recovering agent
ZA200207107B (en) New combination of a betablocker and a cholesterol-lowering agent.
IL153245A0 (en) New formulation comprising a betablocker and optionally a cholesterol-lowering agent
GB0006864D0 (en) New use
AU1046702A (en) New use
AU2001252710A1 (en) Chemically amplified resist and a resist composition
GB0004183D0 (en) New use
AU2001296307A1 (en) 55054, a human metalloprotease and uses therefor
AU2001276025A1 (en) 25233, a human aminotransferase and uses therefor
ZA200105525B (en) Use of cholesterol-lowering agent.
AU2001283380A1 (en) 17903, a human aminopeptidase and uses therefor
GB0106084D0 (en) Moud and Sa'a
GB0027181D0 (en) New use
AUPR064500A0 (en) Anaesthetic reversal agent